BAJAJ BROKING

Notification
No new Notification messages
Vishal Mega Mart IPO is Open!
Apply for the Vishal Mega Mart IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
alkem laboratories ltd. stock

ALKEM LABORATORIES LTD. Share Price

5436.85 -53.10 (-0.96%)
Dec 12 2024 02:59 PM Pharmaceuticals NSE: ALKEM

ALKEM LABORATORIES LTD. Share Price Update

As of the latest trading session, ALKEM LABORATORIES LTD. share price is currently at 5436.85, which is down by -53.10 from its previous closing. Today, the stock has fluctuated between 5405.50 and 5535.00. Over the past year, ALKEM LABORATORIES LTD. has achieved a return of 16.18 %. In the last month alone, the return has been -2.38 %. Read More...

ALKEM LABORATORIES LTD. Performance

Day Range

Low5405.50 High5535.00
5424.85

52 Week Range

Low 4407.05 High 6439.90
5424.85

ALKEM LABORATORIES LTD. Share Price

11703

539523

ALKEM

img img img img
No Data Available

Open Price

5529.45

Prev. Close

5489.95

Volume (Shares)

82255.00

Total traded value

4462.21

Upper Circuit

6038.90

Lower Circuit

4940.95

Note: The current prices & values are delayed, Login to your account for live updates.

ALKEM LABORATORIES LTD. Fundamentals


(Standalone)

Market Cap (Cr) 65005.70
PE Ratio (TTM) 31.11
Book Value / Share 984.45
Beta 0.49
ROE 17.56%
EPS (TTM) 180.88
Dividend Yield 0.73%
Net Profit Qtr (Cr) 697.58

ALKEM LABORATORIES LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 2871.97
Operating Expense 2224.49
Net Profit 697.58
Net Profit Margin (%) 24.28
Earnings Per Share (EPS) 58.34
EBITDA 847.83
Effective Tax Rate (%) 9.13
Particulars JUN 2024 (Values in Cr)
Revenue 2500.10
Operating Expense 1965.26
Net Profit 583.25
Net Profit Margin (%) 23.32
Earnings Per Share (EPS) 48.78
EBITDA 726.73
Effective Tax Rate (%) 9.00
Particulars MAR 2024 (Values in Cr)
Revenue 2365.37
Operating Expense 2047.63
Net Profit 324.97
Net Profit Margin (%) 13.73
Earnings Per Share (EPS) 27.18
EBITDA 478.78
Effective Tax Rate (%) 16.46
Particulars DEC 2023 (Values in Cr)
Revenue 2494.59
Operating Expense 2004.56
Net Profit 504.23
Net Profit Margin (%) 20.21
Earnings Per Share (EPS) 42.17
EBITDA 613.61
Effective Tax Rate (%) 5.64
Particulars SEP 2023 (Values in Cr)
Revenue 2634.59
Operating Expense 2057.71
Net Profit 646.51
Net Profit Margin (%) 24.53
Earnings Per Share (EPS) 54.07
EBITDA 716.44
Effective Tax Rate (%) -1.21
Particulars MAR 2024 (Values in Cr)
Revenue 9747.72
Operating Expense 8108.84
Net Profit 1747.15
Net Profit Margin (%) 17.92
Earnings Per Share (EPS) 146.13
EBITDA 2207.29
Effective Tax Rate (%) 7.11
Particulars MAR 2023 (Values in Cr)
Revenue 9054.55
Operating Expense 7993.84
Net Profit 1134.47
Net Profit Margin (%) 12.52
Earnings Per Share (EPS) 94.88
EBITDA 1643.24
Effective Tax Rate (%) 14.50
Particulars MAR 2022 (Values in Cr)
Revenue 8829.81
Operating Expense 7276.33
Net Profit 1541.25
Net Profit Margin (%) 17.45
Earnings Per Share (EPS) 128.90
EBITDA 2010.25
Effective Tax Rate (%) 12.09
Particulars MAR 2021 (Values in Cr)
Revenue 7219.68
Operating Expense 5512.61
Net Profit 1685.08
Net Profit Margin (%) 23.34
Earnings Per Share (EPS) 140.93
EBITDA 2126.16
Effective Tax Rate (%) 10.57
Particulars MAR 2020 (Values in Cr)
Revenue 6677.08
Operating Expense 5434.98
Net Profit 1264.42
Net Profit Margin (%) 18.93
Earnings Per Share (EPS) 105.75
EBITDA 1563.62
Effective Tax Rate (%) 5.50
Particulars MAR 2024 (Values in Cr)
Book Value / Share 862.57
ROE % 18.72
ROCE % 18.29
Total Debt to Total Equity 0.15
EBITDA Margin 19.22
Particulars MAR 2023 (Values in Cr)
Book Value / Share 756.61
ROE % 11.39
ROCE % 12.48
Total Debt to Total Equity 0.23
EBITDA Margin 14.85
Particulars MAR 2022 (Values in Cr)
Book Value / Share 722.53
ROE % 20.98
ROCE % 18.00
Total Debt to Total Equity 0.28
EBITDA Margin 20.69
Particulars MAR 2021 (Values in Cr)
Book Value / Share 617.04
ROE % 23.90
ROCE % 21.70
Total Debt to Total Equity 0.25
EBITDA Margin 24.54
Particulars MAR 2020 (Values in Cr)
Book Value / Share 515.32
ROE % 19.82
ROCE % 18.07
Total Debt to Total Equity 0.22
EBITDA Margin 18.91
Particulars MAR 2024 (Values in Cr)
Book Value / Share 882.86
ROE % 17.56
ROCE % 17.28
Total Debt to Total Equity 0.11
EBITDA Margin 22.64
Particulars MAR 2023 (Values in Cr)
Book Value / Share 782.09
ROE % 12.54
ROCE % 12.78
Total Debt to Total Equity 0.19
EBITDA Margin 18.15
Particulars MAR 2022 (Values in Cr)
Book Value / Share 731.38
ROE % 18.83
ROCE % 17.47
Total Debt to Total Equity 0.22
EBITDA Margin 22.77
Particulars MAR 2021 (Values in Cr)
Book Value / Share 637.87
ROE % 24.23
ROCE % 22.76
Total Debt to Total Equity 0.19
EBITDA Margin 29.45
Particulars MAR 2020 (Values in Cr)
Book Value / Share 525.34
ROE % 21.53
ROCE % 19.88
Total Debt to Total Equity 0.15
EBITDA Margin 23.42
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1579.35
Total Assets 15574.90
Total Liabilities 15574.90
Total Equity 10714.40
Share Outstanding 119565000
Price to Book Ratio 5.60
Return on Assets (%) 11.52
Return on Capital (%) 15.05
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 2616.89
Total Assets 13756.65
Total Liabilities 13756.65
Total Equity 9435.00
Share Outstanding 119565000
Price to Book Ratio 4.34
Return on Assets (%) 7.15
Return on Capital (%) 9.16
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2578.58
Total Assets 14069.19
Total Liabilities 14069.19
Total Equity 8847.33
Share Outstanding 119565000
Price to Book Ratio 4.95
Return on Assets (%) 11.69
Return on Capital (%) 14.4
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1990.45
Total Assets 11519.26
Total Liabilities 11519.26
Total Equity 7558.01
Share Outstanding 119565000
Price to Book Ratio 4.35
Return on Assets (%) 13.75
Return on Capital (%) 17.12
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1092.21
Total Assets 9945.54
Total Liabilities 9945.54
Total Equity 6308.97
Share Outstanding 119565000
Price to Book Ratio 4.43
Return on Assets (%) 11.33
Return on Capital (%) 14.29
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1065.85
Total Assets 14037.80
Total Liabilities 14037.80
Total Equity 10554.61
Share Outstanding 119565000
Price to Book Ratio 5.60
Return on Assets (%) 12.44
Return on Capital (%) 15.18
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 2163.87
Total Assets 12731.22
Total Liabilities 12731.22
Total Equity 9349.85
Share Outstanding 119565000
Price to Book Ratio 4.34
Return on Assets (%) 8.91
Return on Capital (%) 10.83
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2297.21
Total Assets 13169.17
Total Liabilities 13169.17
Total Equity 8743.66
Share Outstanding 119565000
Price to Book Ratio 4.95
Return on Assets (%) 11.70
Return on Capital (%) 14.03
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1673.36
Total Assets 10772.73
Total Liabilities 10772.73
Total Equity 7625.75
Share Outstanding 119565000
Price to Book Ratio 4.35
Return on Assets (%) 15.64
Return on Capital (%) 18.81
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 765.61
Total Assets 9105.83
Total Liabilities 9105.83
Total Equity 6280.44
Share Outstanding 119565000
Price to Book Ratio 4.43
Return on Assets (%) 13.88
Return on Capital (%) 16.88
Particulars MAR 2024 (Values in Cr)
Net Income 2023.13
Cash from Operations 2355.01
Cash from Investing -1008.50
Cash from Financing -1145.01
Net change in Cash -205.44
Free Cash Flow 2614.30
Particulars MAR 2023 (Values in Cr)
Net Income 1304.77
Cash from Operations 1955.89
Cash from Investing 112.84
Cash from Financing -1760.82
Net change in Cash 34.52
Free Cash Flow 2188.80
Particulars MAR 2022 (Values in Cr)
Net Income 1844.28
Cash from Operations 1507.92
Cash from Investing -1435.13
Cash from Financing 379.57
Net change in Cash 55.46
Free Cash Flow 1846.80
Particulars MAR 2021 (Values in Cr)
Net Income 1842.10
Cash from Operations 1665.58
Cash from Investing -998.54
Cash from Financing -271.75
Net change in Cash -5.39
Free Cash Flow 1860.49
Particulars MAR 2020 (Values in Cr)
Net Income 1259.79
Cash from Operations 868.46
Cash from Investing -741.35
Cash from Financing 79.15
Net change in Cash -77.12
Free Cash Flow 1231.55
Particulars MAR 2024 (Values in Cr)
Net Income 1881.03
Cash from Operations 2039.39
Cash from Investing -865.60
Cash from Financing -959.04
Net change in Cash -138.08
Free Cash Flow 2146.07
Particulars MAR 2023 (Values in Cr)
Net Income 1326.99
Cash from Operations 1661.58
Cash from Investing 197.04
Cash from Financing -1711.27
Net change in Cash -76.81
Free Cash Flow 1803.36
Particulars MAR 2022 (Values in Cr)
Net Income 1753.37
Cash from Operations 1634.19
Cash from Investing -1669.33
Cash from Financing 436.59
Net change in Cash 66.60
Free Cash Flow 1879.06
Particulars MAR 2021 (Values in Cr)
Net Income 1884.30
Cash from Operations 1645.78
Cash from Investing -1120.99
Cash from Financing -208.96
Net change in Cash -5.47
Free Cash Flow 1776.59
Particulars MAR 2020 (Values in Cr)
Net Income 1338.08
Cash from Operations 915.72
Cash from Investing -995.17
Cash from Financing 172.64
Net change in Cash -140.75
Free Cash Flow 1197.81
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.16 37.45 3.55 499.34 37.54 / 77.70
BLISS GVS PHARMA LTD 151.80 19.00 1.58 1598.94 92.25 / 172.40
CIPLA LTD 1454.20 25.44 4.14 117443.01 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 410.00 142.36 4.15 1206.67 145.00 / 440.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.16 56.66 11.07 499.34 37.54 / 77.70
AMRUTAJAN HEALTH LTD 749.55 45.59 7.27 2167.00 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6595.05 128.08 24.26 16487.63 4050.15 / 8139.85
BLISS GVS PHARMA LTD 151.80 19.79 1.56 1598.94 92.25 / 172.40

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 5518.90
  • 26 Days 5595.20
  • 10 Days 5527.30
  • 50 Days 5757.70
  • 12 Days 5531.40
  • 100 Days 5724.20
  • 20 Days 5555.70
  • 200 Days 5411.70
5467.07
PIVOT
First Resistance 5501.13
Second Resistance 5542.82
Third Resistance 5576.88
First Support 5425.38
Second Support 5391.32
Third Support 5349.63
RSI 40.93
MACD -63.82
Commodity Channel Index (CCI) -93.43
ADX 31.90
Williams % R -69.28

Over 1 Month

down

-2.38

Over 3 Months

down

-12.55

Over 6 Months

down

8.35

Over 1 Year

down

16.18

Over 3 Years

down

16.86

Over 5 Years

down

21.33

ALKEM LABORATORIES LTD. Future

Future: Price

26 Dec
5441.50
30 Jan
5484.45
27 Feb
5496.30
25 May
0 100 200 300 400 500 600

Discount/Premium

26 Dec
-1.45
30 Jan
41.50
27 Feb
53.35
25 May
0 1 2 3 4 5 6 7

Active Calls

5500.0
692
5600.0
335
5700.0
323
25 May
0 500 1000 1500 2000 2500 3000

Active Puts

5200.0
251
5400.0
234
5500.0
174
25 Jul
0 500 1000 1500 2000 2500

ALKEM LABORATORIES LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
16.1
Promoter Holdings
55.66
FII
9.02
DII
19.21
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Sarandhar Singh* (please Refer Notes) Shareholding of Promoter and Promoter Group 2.38558E7 19.95
Basudeo Narain Singh Shareholding of Promoter and Promoter Group 8695360.0 7.27
Mritunjay Kumar Singh Shareholding of Promoter and Promoter Group 7682000.0 6.42
Madhurima Singh$ (please Refer Notes) Shareholding of Promoter and Promoter Group 6445745.0 5.39
Icici Prudential Large & Mid Cap Fund Public Shareholding 4124743.0 3.45
Kishor Kumar Singh Public Shareholding 3373312.0 2.82
Madhurima Singh@ (please Refer Notes) Shareholding of Promoter and Promoter Group 3092875.0 2.59
Jayanti Sinha Shareholding of Promoter and Promoter Group 2938220.0 2.46
Alok Kumar Public Shareholding 2764719.0 2.31
Ashok Kumar Public Shareholding 2688000.0 2.25
Seema Singh Shareholding of Promoter and Promoter Group 2579045.0 2.16
Deepak Kumar Singh Public Shareholding 2530783.0 2.12
Archana Singh Shareholding of Promoter and Promoter Group 2394050.0 2.0
Sbi Contra Fund Public Shareholding 2196924.0 1.84
Dsp Midcap Fund Public Shareholding 2071574.0 1.73
Nippon Life India Trustee Ltd-a/c Nippon India Growth Fund Public Shareholding 1909653.0 1.6
Rajesh Kumar Public Shareholding 1684535.0 1.41
Hdfc Life Insurance Company Limited Public Shareholding 1628289.0 1.36
Rajeev Ranjan Public Shareholding 1485342.0 1.24
Government Pension Fund Global Public Shareholding 1310943.0 1.1
Kotak Emerging Equity Scheme Public Shareholding 1255122.0 1.05
Meghna Singh Shareholding of Promoter and Promoter Group 1208650.0 1.01
Divya Singh& (please Refer Notes) Shareholding of Promoter and Promoter Group 1208971.0 1.01
Aniruddha Singh& (please Refer Notes) Shareholding of Promoter and Promoter Group 1208971.0 1.01
Shrey Shree Anant Singh Shareholding of Promoter and Promoter Group 1195650.0 1.0
Madhurima Singh& (please Refer Notes) Shareholding of Promoter and Promoter Group 948194.0 0.79
Shikhar Raj Shareholding of Promoter and Promoter Group 550000.0 0.46
Satyam Sinha Shareholding of Promoter and Promoter Group 550000.0 0.46
Sakshi Sinha Shareholding of Promoter and Promoter Group 550000.0 0.46
Sadhika Raj Shareholding of Promoter and Promoter Group 550000.0 0.46
Raj Kumar Singh Shareholding of Promoter and Promoter Group 538038.0 0.45
Srinivas Singh# (please Refer Notes) Shareholding of Promoter and Promoter Group 102695.0 0.09
Manju Singh# (please Refer Notes) Shareholding of Promoter and Promoter Group 100517.0 0.08
Sarandhar Singh# (please Refer Notes) Shareholding of Promoter and Promoter Group 79800.0 0.07
Satish Kumar Singh# (please Refer Notes) Shareholding of Promoter and Promoter Group 71934.0 0.06
Inderjit Kaur Arora# (please Refer Notes) Shareholding of Promoter and Promoter Group 7800.0 0.01
Sarvesh Singh# (please Refer Notes) Shareholding of Promoter and Promoter Group 1.0 0.0
Premlata Singh# (please Refer Notes) Shareholding of Promoter and Promoter Group 1.0 0.0
Annapurna Singh# (please Refer Notes) Shareholding of Promoter and Promoter Group 1.0 0.0
Sandeep Singh# (please Refer Notes) Shareholding of Promoter and Promoter Group 7.0 0.0

ALKEM LABORATORIES LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2024-02-16 35.0 Interim 2024-02-17 Equity shares 2023-08-10 10.0 Final 2023-08-10 Equity shares 2023-02-17 15.0 Interim 2023-02-18 Equity shares 2023-02-17 25.0 Special 2023-02-18 Equity shares 2022-08-08 4.0 Final 2022-08-10 Equity shares 2022-02-10 30.0 Interim 2022-02-12 Equity shares 2021-08-09 5.0 Final 2021-08-10 Equity shares 2021-02-11 25.0 Interim 2021-02-13 Equity shares 2020-08-10 3.0 Final 2020-08-11 Equity shares 2020-02-13 22.0 Interim 2020-02-15 Equity shares 2019-08-19 8.0 Final 2019-08-20 Equity shares 2019-02-15 8.0 Interim 2019-02-18 Equity shares 2018-08-23 7.0 Final 2018-08-24 Equity shares 2018-02-16 6.0 Interim 2018-02-20 Equity shares 2017-08-31 9.0 Final 2017-09-01 Equity shares 2016-11-23 6.0 Interim 2016-11-24 Equity shares 2016-03-18 9.7 Interim 2 2016-03-21 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About ALKEM LABORATORIES LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by ALKEM LABORATORIES LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Alkem Laboratories Ltd?

Answer Field

The share price of Alkem Laboratories Ltd for NSE is ₹ 5436.85 and for BSE is ₹ 5440.35.

What is the Market Cap of Alkem Laboratories Ltd?

Answer Field

The market cap of Alkem Laboratories Ltd for NSE is ₹ 6,50,05.70 Cr. and for BSE is ₹ 6,50,47.55 Cr. as of now.

What is the 52 Week High and Low of Alkem Laboratories Ltd?

Answer Field

The 52 Week High and Low of Alkem Laboratories Ltd for NSE is ₹ 6439.90 and ₹ 4407.05 and for BSE is ₹ 6440.00 and ₹ 4409.90.

How to Buy Alkem Laboratories Ltd share?

Answer Field

You can trade in Alkem Laboratories Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Alkem Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been 16.18%.

What is the Current Share Price of Alkem Laboratories Ltd?

Answer Field

Alkem Laboratories Ltd share price is for NSE ₹ 5436.85 & for BSE ₹ 5440.35 as on Dec 12 2024 02:59 PM.

What is the Market Cap of Alkem Laboratories Ltd Share?

Answer Field

The market cap of Alkem Laboratories Ltd for NSE ₹ 6,50,05.70 & for BSE ₹ 6,50,47.55 as on Dec 12 2024 02:59 PM.

What is the P/E Ratio of Alkem Laboratories Ltd Share?

Answer Field

As on Dec 12 2024 02:59 PM the price-to-earnings (PE) ratio for Alkem Laboratories Ltd share is 31.11.

What is the PB ratio of Alkem Laboratories Ltd Share?

Answer Field

As on Dec 12 2024 02:59 PM, the price-to-book (PB) ratio for Alkem Laboratories Ltd share is 984.45.

How to Buy Alkem Laboratories Ltd Share?

Answer Field

You can trade in Alkem Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Alkem Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Alkem Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Alkem Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader